Menu
US
prevalence-in-drug-1920x400.jpg
Infographic

GPCRs and their prevalence in drug therapies

Discover GPCRs: basic biology to drug therapies

Up to one third of all commercially available treatments act by binding to G protein coupled-receptors (GPCRs), making them a hot drug target. Agonist and antagonist therapies that target GPCRs are used to treat illness in almost every major organ system and are important in numerous therapeutic areas including oncology, cardiology, neurosciences, respiratory illnesses, metabolic disorders, and rare diseases.

In this infographic, discover:

  • GPCR facts and biology background
  • Specific signaling pathways
  • Existing therapeutics targeting GPCRs

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

GPCRs and their prevalence in drug therapies

Download Infographic